Glenn L.Krinsky

Partner

(T) + 1.213.243.2540

Glenn Krinsky advises academic medical centers and major nonprofit hospital systems in California, throughout the United States, and internationally with respect to their regulatory, transactional, operational, and investigatory affairs. Glenn's experience encompasses the full spectrum of health care delivery system and biomedical research enterprise issues including academic affiliations, corporate governance, technology transfer, and national and international clinical trial research collaborations. He is also one of Jones Day's stateside leaders of its Middle East health care practice.

Glenn has further established himself as one of the nation's foremost practitioners in the representation of organ transplant programs. These representations include complex proceedings before the United Network for Organ Sharing (UNOS) and the Centers for Medicare and Medicaid Services (CMS).

Prior to joining Jones Day, Glenn served as chief legal officer and executive vice president of City of Hope National Medical Center and Beckman Research Institute in Duarte, California, an NCI-designated Comprehensive Cancer Center. He was responsible for all legal issues, as well as matters concerning corporate governance, crisis management, and federal lobbying activities. Glenn supervised City of Hope's 2002 trial against biotechnology industry leader Genentech, which resulted in a jury verdict in excess of $300 million in compensatory damages, a verdict upheld by both the California Court of Appeal and the California Supreme Court. He also successfully defended City of Hope in a comprehensive investigation conducted by the California Attorney General's Office, which resulted in a "no-action" letter, and successfully negotiated with major media organizations, including the CBS News program "60 Minutes" and the Los Angeles Times, regarding coverage of the issues presented in the attorney general's investigation.

Experience

St. Jude and Juno secure $12.25 million settlement resolving patent dispute with Novartis Pharmaceuticals and University of Pennsylvania
Jones Day represented St. Jude Children's Research Hospital ("St. Jude") in enforcing breach of contract claims and defending patent invalidity claims against the University of Pennsylvania ("Penn") and Novartis Pharmaceuticals ("Novartis").

Hoag Memorial Hospital forms regional health system
Jones Day assisted Hoag Memorial Hospital Presbyterian in its affiliation with St. Joseph Health to form an integrated regional health system.

City of Hope forms City of Hope Medical Foundation
Jones Day advised the City of Hope in connection with the development and formation of City of Hope Medical Foundation (COHMF) and the purchase by COHMF of California Cancer Specialists Medical Group (CCSMG) and Oncology Specialists of COH (OSCOH).

High Road Capital acquires Advanced Sleep Medicine Services
Jones Day advised High Road Capital Partners in connection with its acquisition and related financing of Advanced Sleep Medicine Services, Inc., a leading provider of sleep diagnostic services and sleep-related Durable Medical Equipment (DME) in Southern California.

Additional Publications

  • April 2018The Shifting Landscape of Organ Allocation for Transplantation
  • September 2015HHS Proposes Revisions to the Common Rule for Protection of Human Research Subjects
  • September 2013Expansion by the Acquisition of Financially Distressed Health Care Facilities and Companies: Opportunities and Challenges
  • August 2013California Hospitals and Health Care Systems Beware: Proposed California Bill Would Require Payment of Prevailing Wages on Construction Funded by Conduit Revenue Bonds
  • February 2012CMS Publishes Long-Awaited 60-Day Repayment Proposed Rule for Identified Overpayments
  • April 2011Health Care Compliance and Enforcement Update

Speaking Engagements

  • April 6, 2017"Key Legal Considerations in Physician and Hospital Relationships" - Texas Medical Center Innovation Institute
We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.